Comparison of assays for determination of peptide content for lyophilized thymalfasin.
Precise determination of the peptide content in drug substance samples depends highly upon the particular peptide compound and methodology used. Four independent methods were evaluated and compared to determine which would produce the best experimental precision for analysis of thymalfasin (thymosin alpha-1). Four different methods were evaluated including elemental analysis (CHN), quantitative amino acid analysis (AAA), high-performance liquid chromatography (HPLC), and Kjeldahl. This study demonstrates that the AAA method is highly variable in one laboratory while quite precise in another laboratory. Similarly, HPLC results depended on the laboratory conducting the study with more precise values obtained under cGMP. On the contrary, the CHN method yielded highly precise [i.e. <2% coefficient of variation (CV)] values. As precise knowledge of protein content is fundamental for the compounding of final pharmaceutical product of a specific potency, the CHN analysis is recommended for peptide content determination of the drug substance thymalfasin.
Vemuri
S
S
SciClone Pharmaceuticals, Inc., 901 Mariner's Island Blvd, San Mateo, CA 94404, USA. svemuri@sciclone.com
D000595:Amino Acid Sequence; D000596:Amino Acids / Q000032:analysis*; D002851:Chromatography, High Pressure Liquid; D005612:Freeze Drying; D008969:Molecular Sequence Data; D009584:Nitrogen / Q000032:analysis; D010455:Peptides / Q000032:analysis*; D000077596:Thymalfasin; D013947:Thymosin / Q000031:analogs & derivatives* / Q000737:chemistry*
D000596:Amino Acids; D010455:Peptides; D013947:Thymosin; D009584:Nitrogen; D000077596:Thymalfasin